Crossmark

The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People

Crossref DOI link: https://doi.org/10.1007/s40266-019-00703-7

Published Online: 2019-08-22

Published Print: 2019-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rabenberg, Andree

Schulte, Timo

Hildebrandt, Helmut

Wehling, Martin
License Information

Text and Data Mining valid from 2019-08-22

Version of Record valid from 2019-08-22
More Information

Article History

First Online: 22 August 2019

Compliance with Ethical Standards

:

: No external funding was provided for this study and/or the writing of the manuscript.

: Martin Wehling was employed by AstraZeneca R&D, Mölndal, as the director of discovery medicine (translational medicine) from 2003 to 2006, while on sabbatical leave from his professorship at the University of Heidelberg. Since returning to this position in January 2007, he has received lecturing and consulting fees from Sanofi-Aventis, Bayer, Berlin-Chemie, Boehringer-Ingelheim, Aspen, Novartis, Takeda, Roche, Pfizer, Bristol-Myers, Daichii-Sankyo, Lilly, Otsuka, Novo-Nordisk, Shire, and LEO Pharma. Andree Rabenberg, Timo Schulte, and Helmut Hildebrandt have no conflicts of interest to declare.

Document is current

Any future updates will be listed below